Healthcare News and Research

Latest Healthcare News and Research

Unsafe prescribing increases risk of life threatening asthma attacks

Last year’s National Review of Asthma Deaths highlighted prescribing errors in nearly half of asthma deaths in primary care (47%). Now new analysis from Asthma UK, based on data from over 500 UK GP practices, reveals evidence that over 22,000 people with asthma in the UK, including 2,000 children, have been prescribed medicines (long-acting reliever inhalers) in a way that is so unsafe they have a ‘black box warning’ in the USA due to the risk they pose to the lives of people with asthma.

18 Jun 2015

Beckman Coulter brings new thinking to new lab challenges at EuroMedLab 2015

Beckman Coulter Diagnostics supports IFCC-EFLM EuroMedLab 2015 with a showcase of solutions to improve workflow for the diagnostics laboratory. Held from 22-24 June 2015 at the Paris Palais des Congrès France, the company demonstrates its dedication to moving the clinical diagnostic lab forward with its total laboratory solution—from automation, chemistry, immunoassay and haematology to microbiology and its new molecular diagnostics system.

From Beckman Coulter Diagnostics 18 Jun 2015

New depression treatment from Magstim to be exhibited at Royal College of Psychiatry International Congress 2015

The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, will be showing its Magstim Rapid2 Therapy System at the Royal College of Psychiatry International Congress 2015 in Birmingham, UK, 29th June-2nd July.

From Magstim 17 Jun 2015

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

A recent study presented at the American College of Cardiology 64th Annual Scientific Meeting evaluated the impact of an age, sex, and gene expression score on clinical decision-making and the rate of further cardiac evaluation in symptomatic female patients suggestive of CAD in the outpatient setting.

17 Jun 2015

PAH diagnosis delayed for adult congenital heart disease patients

Pulmonary arterial hypertension is often not diagnosed in adult patients with congenital heart disease until 6 years or more after their symptoms first appear, research shows.

17 Jun 2015

Bivalent HPV vaccine efficacy may be independent of dose

Fewer than three doses of the bivalent human papillomavirus vaccine may be sufficient to offer adequate protection against cervical HPV-16 and -18 infection, research published in The Lancet Oncology indicates.

17 Jun 2015

AMGA submits comments on proposed rule to modify Meaningful Use in 2015 through 2017

Today, the American Medical Group Association (AMGA) submitted comments to the Centers for Medicare and Medicaid Services (CMS) making recommendations on the proposed rule to modify Meaningful Use in 2015 through 2017.

17 Jun 2015

Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

Eli Lilly and Company and Sarah Cannon Research Institute today announced a strategic partnership to co‑develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor. Under the agreement, SCRI will collaborate with Lilly to provide clinical development expertise and program design, as well as medical oversight and trial management. Patient enrollment for the initial Phase II clinical trial is underway.

17 Jun 2015

Heparin market in Europe estimated to reach USD 3,148.0 million by 2022

According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022" the Heparin Market Europe was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022.

17 Jun 2015

Warm Springs Specialty Hospital of New Braunfels achieves Gold Seal of Approval for Respiratory Failure Certification

Warm Springs Specialty Hospital of New Braunfels, a Post Acute Medical facility, today announced that it has earned The Joint Commission's Gold Seal of Approval for Respiratory Failure Certification. The Gold Seal of Approval is a symbol of quality that reflects an organization's commitment to providing safe and effective patient care.

17 Jun 2015

Wilson Therapeutics supports BIG WOW event to increase awareness of Wilson's Disease

Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced its sponsorship of the first annual Big Walk on Wilson's (BIG WOW). The event will take place on September 19, 2015 in sixteen cities across North America to increase awareness of Wilson's Disease and raise funds for the Wilson Disease Association.

17 Jun 2015

Allergan agrees to acquire KYTHERA Biopharmaceuticals for $2.1 billion

Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.

17 Jun 2015

Hill-Rom, Welch Allyn joining forces to advance patient care around the world

Two of the world's leading healthcare technology companies are joining forces to make possible the development of leading-edge solutions that will advance patient care around the world. Hill-Rom Holdings, Inc. and privately-held Welch Allyn, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Hill-Rom will acquire Welch Allyn for approximately $2.05 billion in cash and stock.

17 Jun 2015

Earthquake-ravaged Nepal faces 'very high' risk of hepatitis E outbreak

During the coming monsoon season, survivors of the recent earthquake that destroyed parts of Nepal face a "very high" risk of a hepatitis E outbreak that could be especially deadly to pregnant women, according to a consensus statement from a group of infectious disease experts from around the world.

17 Jun 2015

Research finding could help develop artificial retinas for people with vision loss

Driving a car at 40 mph, you see a child dart into the street. You hit the brakes. Disaster averted. But how did your eyes detect that movement? It's a question that has confounded scientists. Now, studying mice, researchers at Washington University School of Medicine in St. Louis have an answer: A neural circuit in the retina at the back of the eye carries signals that enable the eye to detect movement.

17 Jun 2015

Selecting health insurance plan on HealthCare.gov particularly challenging for young adults

When trying to enroll in a health insurance plan through HealthCare.gov during the first open enrollment period of the Affordable Care Act's (ACA) health insurance marketplaces, young adults were confused by unfamiliar health insurance terms, concerned about the affordability of plan options, and unsure how to seek good primary care.

17 Jun 2015

Two substantial gifts to support launch of integrative medicine program at Meridian Health

Riverview Medical Center Foundation is proud to announce two substantial gifts, totaling $10 million, which will significantly impact the way health care is delivered in our community. First, Joan and Robert Rechnitz, founders of the Two River Theater Company, donated $5 million to Riverview Medical Center Foundation to support the launch of an integrative medicine program.

17 Jun 2015

Atopix raises additional development capital to investigate OC459 for treatment of asthma

Atopix Therapeutics Limited, a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product OC459 for the treatment of asthma.

17 Jun 2015

Bayer HealthCare, Johns Hopkins University to jointly develop new ophthalmic therapies targeting retinal diseases

The Johns Hopkins University and Bayer HealthCare have entered into a five-year collaboration agreement to jointly develop new ophthalmic therapies targeting retinal diseases. The goal of the strategic research alliance is to accelerate the translation of innovative approaches from the laboratory to the clinic, ultimately offering patients new treatment options for several retinal diseases.

17 Jun 2015

CytomX closes $70 million Series D financing round

CytomX, a biotechnology company developing Probody™ therapeutics for the treatment of cancer, today announced the closing of a $70 million Series D financing round. The financing was led by Fidelity Management & Research Company with participation from Casdin Capital, Cormorant Asset Management, Deerfield Management, Perceptive Advisors, Redmile Group, Tekla Healthcare Investors and Tekla Life Sciences Investors, Venrock Healthcare Capital Partners, Wellington Management Company and additional undisclosed investors.

17 Jun 2015

Healthcare News and Research

Latest Healthcare News and Research

Unsafe prescribing increases risk of life threatening asthma attacks

Beckman Coulter brings new thinking to new lab challenges at EuroMedLab 2015

New depression treatment from Magstim to be exhibited at Royal College of Psychiatry International Congress 2015

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

PAH diagnosis delayed for adult congenital heart disease patients

Bivalent HPV vaccine efficacy may be independent of dose

AMGA submits comments on proposed rule to modify Meaningful Use in 2015 through 2017

Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

Heparin market in Europe estimated to reach USD 3,148.0 million by 2022

Warm Springs Specialty Hospital of New Braunfels achieves Gold Seal of Approval for Respiratory Failure Certification

Wilson Therapeutics supports BIG WOW event to increase awareness of Wilson's Disease

Allergan agrees to acquire KYTHERA Biopharmaceuticals for $2.1 billion

Hill-Rom, Welch Allyn joining forces to advance patient care around the world

Earthquake-ravaged Nepal faces 'very high' risk of hepatitis E outbreak

Research finding could help develop artificial retinas for people with vision loss

Selecting health insurance plan on HealthCare.gov particularly challenging for young adults

Two substantial gifts to support launch of integrative medicine program at Meridian Health

Atopix raises additional development capital to investigate OC459 for treatment of asthma

Bayer HealthCare, Johns Hopkins University to jointly develop new ophthalmic therapies targeting retinal diseases

CytomX closes $70 million Series D financing round

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in